Browsing Centre for Genomics and Child Health by Author "Otter, A"
Now showing items 1-3 of 3
-
Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial.
Abhishek, A; Peckham, N; Pade, C; Gibbons, JM; Cureton, L; Francis, A; Barber, V; Williams, JAE; Appelbe, D; Eldridge, L (2024-02)BACKGROUND: Methotrexate is the first-line treatment for immune-mediated inflammatory diseases and reduces vaccine-induced immunity. We evaluated if a 2-week interruption of methotrexate treatment immediately after COVID-19 ... -
HLA-DR polymorphism in SARS-CoV-2 infection and susceptibility to symptomatic COVID-19
Astbury, S; Reynolds, CJ; Butler, DK; Munoz-Sandoval, DC; Lin, K-M; Pieper, FP; Otter, A; Kouraki, A; Cusin, L; Nightingale, J (2022) -
Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infection
Milighetti, M; Peng, Y; Tan, C; Mark, M; Nageswaran, G; Byrne, S; Ronel, T; Peacock, T; Mayer, A; Chandran, A (2023)